CARMEN AMESTOY: Open Payments
NPI 1972083426 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,611 in 129 payments from 15 companies in 2025. Trend: 2023 $104 · 2024 $1,960 · 2025 $2,611
Food & beverage: $2,512Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $462 |
| Janssen Biotech, Inc. | 16 | $442 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $341 |
| Madrigal Pharmaceuticals | 9 | $232 |
| Amgen Inc. | 5 | $206 |
| Ardelyx, Inc. | 12 | $197 |
| Lilly USA, LLC | 12 | $189 |
| Phathom Pharmaceuticals, Inc. | 3 | $164 |
| Aimmune Therapeutics, Inc. | 4 | $86 |
| Novo Nordisk Inc | 3 | $77 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, OMVOH, RINVOQ, VOQUEZNA, ENTYVIO, LINZESS.
Industry payments across FL — which companies pay providers there.
